 Released: Jul 1, 2008
 Expires: Jun 30, 2009
 Type: PDF
The International Journal of Advances in Rheumatology, a CME/CPE/CNE-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of rheumatoid diseases. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that...
|
- CME Credits/Hours: 2.00
- CPE Credits/Hours: 2.00
- CNE Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
 Released: Apr 30, 2008
 Expires: Apr 30, 2009
 Type: Audio
In the United States, sepsis is the leading cause of death in non-coronary ICU patients, and the tenth most common cause of death overall according to data from the Centers for Disease Control and Prevention. Sepsis is common and also more dangerous in elderly, immunocompromised, and critically ill patients. It occurs in 1%-2% of all hospitalizations and accounts for as much as 25%...
|
- CME Credits/Hours: 0.75
- Cost: Free
-
System Requirements:
|
 Released: Mar 1, 2008
 Expires: Mar 1, 2009
 Type: Audio
Inadequate initial coverage of infections in ICU patients is associated with an increase in mortality. Prolonged time to initiation of antimicrobial therapy is also associated with increased mortality. Numerous factors exist which may hinder the most optimal care. Practitioners should be aware of the literature regarding this issue and engage in strategies to increase efficiency...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Mar 2, 2008
 Expires: Mar 1, 2009
 Type: PDF
Each issue of the International Journal of Advances in Rheumatology will present carefully constructed, leading (review) articles, written by practicing rheumatologists and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief,...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 28, 2008
 Expires: Feb 28, 2009
 Type: Video
This presentation aims to focus on current strategies to optimize oral antiplatelet agents in the treatment of ACS and PCI. Topics addressed include current limitations with clopidogrel, variability in response to clopidogrel and the clinical outcomes associated with poor response, and strategies to reduce variability. Finally, a comparison of the biologic response of prasugrel and...
|
- CME Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 28, 2008
 Expires: Feb 28, 2009
 Type: Video
This presentation focuses on the results of the TRITON-TIMI 38 trial, which examines the use of the investigational thienopyridine prasugrel compared to clopidogrel in patients with ACS who were undergoing primary PCI. Highlighted data from the trial is presented, including several in-depth analyses investigating sub-populations as it relates to ischemic endpoints as well as...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 28, 2008
 Expires: Feb 28, 2009
 Type: Video
This presentation aims to address the central role of platelets in acute coronary syndromes (ACS) and the use of both oral antiplatelet therapy and interventional therapy as cornerstones for the treatment of ACS. Topics to be discussed include the pharmacology of approved and investigational oral antiplatelet agents, clinical trial data detailing the use of...
|
- CME Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 28, 2008
 Expires: Feb 27, 2009
 Type: Audio
According to data from the National Nosocomial Infections Surveillance (NNIS) System in 2003, the Gram-negative pathogen Pseudomonas aeruginosa was the second most common pathogen causing nosocomial pneumonia in the intensive care unit (ICU), responsible for 18.1% of these infections. Acinetobacter spp also caused hospital-acquired pneumonia (HAP) and accounted for...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 15, 2008
 Expires: Feb 14, 2009
 Type: PDF
Rheumatology Highlights, a CME-accredited educational program, presents a carefully constructed report from a major international conference and is developed to equip readers with practical knowledge of the area under discussion. This newsletter is commissioned to support particular educational themes identified by the Editor-in-Chief, Editorial team and readers. This issue...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Dec 1, 2007
 Expires: Nov 30, 2008
 Type: PDF
Advances in Sepsis, a CME-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of severe sepsis and septic shock. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that will have most impact on...
| Faculty: |
Benoit Vallet, MD, PhD;
Herve Tytgat, MD;
Gilles LeBuffe, MD;
Giorgio Berlot, MD;
Barbara Bacer, MD;
Marco Piva, MD;
Umberto Lucangelo, MD;
Marino Viviani, MD;
Catherine S. Bouman, MD, PhD
|
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
 Released: Nov 19, 2007
 Expires: Nov 19, 2008
 Type: PDF
The trend to minimize the use of calcineurin inhibitors (CNIs) and corticosteroids (CSs) has contributed to an increase in the use of antibody induction therapy in kidney and liver transplantation. Significant comorbid conditions associated with historical maintenance immunosuppressive regimens consisting of CNIs and CSs have resulted in a paradigm shift in clinical practice....
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.20
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Nov 15, 2007
 Expires: Nov 15, 2008
 Type: PDF
Currently, three tumor necrosis factor (TNF) antagonists are approved for the treatment of patients with rheumatoid arthritis (RA): infliximab, etanercept, and adalimumab. Whilst, overall, TNF antagonists are well tolerated and have demonstrated a favorable risk–benefit profile, there are lingering concerns over their long-term safety. For example, data from clinical trials...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
 Released: Nov 5, 2007
 Expires: Nov 4, 2008
 Type: PDF
Each issue of the International Journal of Advances in Rheumatology will present carefully constructed, leading (review) articles, written by practicing rheumatologists and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in-Chief, Editorial...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
 Released: Oct 29, 2007
 Expires: Oct 29, 2008
 Type: Audio
Transplantation is a unique therapeutic option for patients with end organ disease. The pharmacotherapy involved in the treatment of the transplant patient is often challenging. Immunosuppressive agents used have narrow therapeutic indices and have the potential for long term toxicity. More and more patients are transplanted every year. Community pharmacists will encounter this...
|
- CPE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Oct 5, 2007
 Expires: Oct 5, 2008
 Type: Audio
Acute Respiratory Distress Syndrome (ARDS) affects thousands of hospitalized patients annually. Although many patients demonstrate some clinical criteria for ARDS the diagnosis is specific and should be made accurately. Likewise, many therapies for ARDS are based upon strong clinical evidence while others are more anecdotal and less well-established. This presentation will concisely...
|
- CME Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Oct 5, 2007
 Expires: Oct 5, 2008
 Type: Audio
Almost 2,000,000 Americans are brain-injured every year and mortality and long-term morbidity from brain injury are common. Early aggressive emergency care, efforts to reduce secondary brain injury and rapid transfer to a trauma center are essential to optimize neurologic outcome. This presentation discusses epidemiology, diagnosis, stabilization, priorities of ICU care and...
|
- CME Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Sep 28, 2007
 Expires: Sep 28, 2008
 Type: PDF
According to 2003 data from the US Centers for Disease Control and Prevention, approximately 1.1 million Americans are living with HIV/AIDS, with more than 25% of those individuals thought to be undiagnosed and unaware of their illness. Furthermore, the annual cost of newly diagnosed HIV cases, according to 2002 data, is an estimated $36.4 billion. There is no cure for HIV. Goals of...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Aug 1, 2007
 Expires: Aug 31, 2008
 Type: PDF
Rising rates of nosocomially acquired multidrug-resistant (MDR) Gram negative pathogens have drastically narrowed the spectrum of available therapeutic options. Resistance to antimicrobials is a mounting health concern, both in the United States and worldwide. Infections caused by resistant Gram-negative pathogens, such as Pseudomonas aeruginosaand Acinetobacter baumannii, result in...
|
- CME Credits/Hours: 1.50
- Cost: Free
-
System Requirements:
|
 Released: Jul 1, 2007
 Expires: Jul 31, 2008
 Type: PDF
As confirmed by numerous reports and surveillance studies, multidrugresistant (MDR) Gram-negative pathogens such as Pseudomonas aeruginosa and Acinetobacter baumannii are increasing worldwide and pose a considerable public health threat, particularly among hospitalized patients. Data from the National Nosocomial Infections Surveillance (NNIS)System indicate that Gram-negative...
|
- CME Credits/Hours: 1.50
- Cost: Free
-
System Requirements:
|
|